Revolutionary psychiatrist transforms global understanding of treatment-resistant depression

Professor Siegfried Kasper reveals groundbreaking insights linking brain biology to psychiatric treatment worldwide

2025-09-02

(Press-News.org) VIENNA, AUSTRIA, 2 September 2025 -- In a compelling Genomic Press Interview published today in Brain Medicine, Professor Siegfried Kasper shares extraordinary insights from his distinguished career that has transformed global understanding of psychiatric disorders and their treatment. The interview reveals how this internationally renowned psychiatrist revolutionized approaches to treatment-resistant depression while establishing biological psychiatry as a cornerstone of modern medicine worldwide.

Professor Kasper, who serves as Professor Emeritus at the Medical University of Vienna's prestigious Center for Brain Research, has fundamentally reshaped how the international scientific community understands and treats psychiatric conditions. His groundbreaking research demonstrating that psychiatric disorders have biological bases alongside psychosocial determinants has influenced treatment protocols across continents and improved millions of lives globally.

Transforming Global Psychiatric Practice Through Scientific Discovery

The interview illuminates Professor Kasper's journey from his early fascination with brain anatomy as a medical student to becoming Austria's most frequently cited psychiatrist. His pivotal moment came when studying at the Central Institute of Mental Health in Mannheim, Germany, where he connected Michel Jouvet's animal research on raphe nuclei lesions with the sleep disturbances he observed in depressed patients. This insight launched his pioneering research into the serotonergic system in depression, challenging the then-dominant norepinephrine theory.

"I realized that this is precisely what I do see in my patients: they cannot sleep," Professor Kasper recalls in the interview. This observation led to decades of transformative research that would reshape psychiatric treatment worldwide. His subsequent work at the National Institute of Mental Health in the United States expanded into circadian rhythms and seasonal affective disorder, where he conducted the first epidemiological study demonstrating latitude-dependent variations in mood disorders across North America.

Professor Kasper's research has consistently bridged laboratory discoveries with clinical applications, exemplifying what he calls "back-translation" from clinical observations to basic science. This approach has yielded remarkable breakthroughs that continue to influence psychiatric practice internationally.

Revolutionary Treatments Changing Lives Across Continents

Throughout his career, Professor Kasper has been instrumental in introducing and validating revolutionary psychiatric treatments now used globally. His work establishing the efficacy of selective serotonin reuptake inhibitors transformed depression treatment in countless countries. He also pioneered research on atypical antipsychotics for schizophrenia, demonstrating their effectiveness for depressive and negative symptoms with improved side effect profiles compared to older compounds.

One particularly fascinating discovery emerged serendipitously through interdisciplinary collaboration. When a colleague from the Department of Epileptology mentioned that patients seemed happier after transcranial magnetic stimulation used to identify epileptogenic foci, Professor Kasper immediately recognized the potential psychiatric application. After personally experiencing the procedure to ensure its safety, he introduced TMS for depression treatment, establishing foundations for what has become a worldwide therapeutic approach.

More recently, his leadership of the European Group for the Study of Resistant Depression has redefined how the global medical community understands and treats treatment-resistant depression. The group's analysis of over 3000 patients across Europe established criteria subsequently adopted by the European Medicines Agency and used in developing intranasal esketamine, now available internationally.

Advancing Science Through International Leadership

Professor Kasper's influence extends far beyond individual discoveries through his leadership of major international psychiatric organizations. As founding president of the Austrian Society of Neuropsychopharmacology and Biological Psychiatry, former President of the World Federation of Societies of Biological Psychiatry, and former President of the International College of Neuropsychopharmacology, he has shaped global research priorities and clinical standards that benefit patients worldwide.

His extraordinary achievements have earned him Austria's highest honors, including the Grand Decoration of Honor in Silver for Services to the Republic of Austria, the Austrian Cross of Honor for Science and Art First Class, and most recently, the 2025 CINP Pioneer Award recognizing his lifetime contributions to advancing psychiatric science globally.

The interview also reveals Professor Kasper's dedication to mentoring the next generation of researchers across continents. He describes fostering an environment where young scientists question established paradigms while maintaining rigorous scientific standards. This commitment to education ensures his transformative approaches to psychiatric research and treatment will continue benefiting humanity for generations.

Humanizing Scientific Excellence

Beyond his scientific achievements, the Genomic Press interview provides glimpses into Professor Kasper's personal philosophy and motivations. His love of nature, dedication to his informal scientific outpost in Puglia, Italy, and companionship with his Lakeland terrier reveal a scientist who finds inspiration beyond laboratory walls. These personal elements underscore how great scientific minds draw insights from diverse life experiences.

Professor Kasper emphasizes the importance of listening carefully to patients while maintaining awareness of scientific literature, embodying Louis Pasteur's principle that "chance favors only the prepared mind." This philosophy has enabled him to recognize patterns others might miss, leading to discoveries that have transformed psychiatric treatment globally. Readers interested in exploring more about leading scientists reshaping medicine can discover additional interviews at https://genomicpress.kglmeridian.com/.

Professor Kasper's Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today's most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that explore the scientist's impact on the field, while also touching on broader human themes. More information on the research leaders and rising stars featured in our Innovators & Ideas -- Genomic Press Interview series can be found on our publications website: https://genomicpress.kglmeridian.com/.

The Genomic Press Interview in Brain Medicine titled "Siegfried Kasper: The importance of back-translation of clinical findings to basic science," is freely available via Open Access on 2 September 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025k.0104.

About Brain Medicine: Brain Medicine (ISSN: 2997-2639, online and 2997-2647, print) is a peer-reviewed medical research journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal's scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.

Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/

Our full website is at: https://genomicpress.kglmeridian.com/

END

ELSE PRESS RELEASES FROM THIS DATE:

“Greetings from 51 Pegasi b”: How NASA made exoplanets into tourist destinations

2025-09-02

Looking for the perfect vacation? Do you crave late-night fun? PSO J318.5−22, the planet with no star where nightlife never ends, is perfect for you! Prefer some peace and a chance to catch some rays? Kepler-16b, the land of two suns—where your shadow always has company—is waiting! In 2015, NASA launched an unusual and brilliant exoplanet outreach campaign, offering retro-style posters, virtual guided tours, and even coloring books. The project quickly went viral worldwide. What explains the success of a campaign about a relatively young field of science that—unlike other areas of space research—lacks spectacular imagery? Ceridwen Dovey, science communicator, ...

Study reveals global inequalities in cancer research funding

2025-09-01

Researchers at the University of Southampton examining worldwide variations in funding for cancer research say there’s a pressing need to invest more in lower income countries. They also reveal research into certain treatments urgently need more money, in particular surgery and radiotherapy, and that overall annual research investment has largely decreased, globally, since 2016. The team’s study, due for publication in the journal The Lancet Oncology, shows most research income is concentrated in higher income countries, leaving others struggling to keep pace ...

England’s forgotten first king deserves to be famous, says Æthelstan biographer as anniversaries approach

2025-09-01

University of Cambridge media release England’s forgotten first king deserves to be famous, says Æthelstan biographer as anniversaries approach UNDER STRICT EMBARGO UNTIL 19:01 (US ET) ON MONDAY 1ST SEPTEMBER 2025 / 00:01AM (UK TIME) ON TUESDAY 2ND SEPTEMBER 2025 A groundbreaking new biography of Æthelstan marks 1,100 years since his coronation in 925AD, reasserts his right to be called the first king of England, explains why he isn’t better known and highlights his many overlooked achievements. The book’s author, Professor David Woodman, is campaigning for greater public recognition ...

Experts urge the medical profession to confront the global arms industry

2025-09-01

As the UK and other NATO nations dramatically increase defence spending to counter growing global aggressions, one under-recognised aspect of security debates is the role of the arms industry. And as London prepares to host the world’s largest arms fair next week, health professionals must do more to counterbalance the arms industry’s influence on government agendas and its damaging effects on human and planetary health, say experts in The BMJ. In a series of articles published today, Mark Bellis at Liverpool John Moores University and international colleagues lay out the direct and wider harms ...

Personalized risk messages fail to boost colorectal cancer screening participation

2025-09-01

Embargoed for release until 5:00 p.m. ET on Monday 1 September 2025 Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...

Something from nothing: Physicists model vacuum tunnelling in a 2D superfluid

2025-09-01

In 1951, physicist Julian Schwinger theorized that by applying a uniform electrical field to a vacuum, electron-positron pairs would be spontaneously created out of nothing, through a phenomenon called quantum tunnelling. The problem with turning the matter-out-of-nowhere theory into Star Trek replicators or transporters? Enormously high electric fields would be required—far beyond the limits of any direct physical experiments. As a result, the aptly named Schwinger effect has never been seen. Now theoretical physicists at the University of British Columbia (UBC) have described a parallel effect in a more manageable system. In their model, ...

CRISPR’s efficiency triples with DNA-wrapped nanoparticles

2025-09-01

With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and efficiently into relevant cells and tissues, that promise will remain out of reach. Now, Northwestern University chemists have unveiled a new type of nanostructure that dramatically improves CRISPR delivery and potentially extends its scope of utility. Called lipid nanoparticle spherical nucleic acids (LNP-SNAs), these tiny structures carry the full set of CRISPR editing tools — Cas9 enzymes, ...

For the first time in 40 Years, Panama’s deep and cold ocean waters failed to emerge, possibly affecting fisheries and coral health

2025-09-01

During the dry season in Central America (generally between December and April), northern trade winds generate upwelling events in the ocean waters of the Gulf of Panama. Upwelling is a process that allows cold, nutrient-rich waters from the depths of the ocean to rise to the surface. This dynamic supports highly productive fisheries and helps protect coral reefs from thermal stress. Thanks to this movement of water, the sea along Panama’s Pacific beaches remains cooler during the "summer" vacation season. Scientists from the Smithsonian Tropical Research Institute (STRI) have studied this phenomenon and their records show that this seasonal upwelling, ...

Depression may make learning to avoid unpleasant events harder

2025-09-01

Depression alters how people pursue rewards, but, conversely, whether depressive symptoms influence how people learn to avoid nonrewarding, unpleasant events is less clear. Ryan Tomm and colleagues, from the University of British Colombia, addressed this question in their eNeuro paper to shed more light on the relationship between depression and learning. This work brought together researchers from preclinical, cognitive, and clinical backgrounds, building stronger connections across fields to better understand the mechanisms of depression. The researchers developed a behavioral task for study volunteers based off rodent research ...

Study sheds light on how pediatric brain tumors grow

2025-09-01

The most common type of brain tumor in children, pilocytic astrocytoma (PA), accounts for about 15% of all pediatric brain tumors. Although this type of tumor is usually not life-threatening, the unchecked growth of tumor cells can disrupt normal brain development and function. Current treatments focus mainly on removing the tumor cells, but recent studies have shown that non-cancerous cells, such as nerve cells, also play a role in brain tumor formation and growth, suggesting novel approaches to treating these cancers. Scientists have long known that a nerve cell signaling chemical called glutamate can increase growth of cancers throughout the body, but despite ...

LAST 30 PRESS RELEASES:

The tipping of the last resilient glaciers

No-sort plastic recycling is near

Scientists reveal brain signaling that sets Parkinson’s disease apart from essential tremor

Pioneering strategy may keep breast cancer from coming back

Scientists investigate why memory circuits break down in Alzheimer’s disease

Psychedelic research transforms global mental health treatment paradigms